- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2051-5960
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Models of α-synuclein aggregation in Parkinson’s disease ; volume:2 ; number:1 ; day:13 ; month:12 ; year:2014 ; pages:1-17 ; date:12.2014
Acta Neuropathologica Communications ; 2, Heft 1 (13.12.2014), 1-17, 12.2014
- Urheber
-
Giráldez-Pérez, Rosa María
- Beteiligte Personen und Organisationen
-
Antolín-Vallespín, Mónica
Muñoz, María Dolores
Sánchez-Capelo, Amelia
SpringerLink (Online service)
- DOI
-
10.1186/s40478-014-0176-9
- URN
-
urn:nbn:de:1111-201608026435
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:45 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Giráldez-Pérez, Rosa María
- Antolín-Vallespín, Mónica
- Muñoz, María Dolores
- Sánchez-Capelo, Amelia
- SpringerLink (Online service)
Ähnliche Objekte (12)
Fasudil attenuates aggregation of α-synuclein in models of Parkinson’s disease
Dermal α-synuclein oligomers and aggregates in Parkinson’s disease
Role of Apolipoproteins and α-Synuclein in Parkinson’s Disease
Phosphorylated α-synuclein in Parkinson’s disease: correlation depends on disease severity
Erythrocytic α-Synuclein as a potential biomarker for Parkinson’s disease
Initiation and progression of α-synuclein pathology in Parkinson’s disease
Structure and dynamics of the aggregation mechanism of the Parkinson's disease-associated protein α-synuclein [alpha-synuclein]
GM1 Ganglioside Modifies α-Synuclein Toxicity and is Neuroprotective in a Rat α-Synuclein Model of Parkinson’s Disease
Retinal α-synuclein deposits in Parkinson’s disease patients and animal models
Characterization of the pathogenic α-Synuclein Variant V15A in Parkinson´s disease
Association of Glial Activation and α-Synuclein Pathology in Parkinson’s Disease
Long-term hyperglycemia aggravates α-synuclein aggregation and dopaminergic neuronal loss in a Parkinson’s disease mouse model
Fasudil attenuates aggregation of α-synuclein in models of Parkinson’s disease
Dermal α-synuclein oligomers and aggregates in Parkinson’s disease
Role of Apolipoproteins and α-Synuclein in Parkinson’s Disease
Phosphorylated α-synuclein in Parkinson’s disease: correlation depends on disease severity
Erythrocytic α-Synuclein as a potential biomarker for Parkinson’s disease
Initiation and progression of α-synuclein pathology in Parkinson’s disease
Structure and dynamics of the aggregation mechanism of the Parkinson's disease-associated protein α-synuclein [alpha-synuclein]
GM1 Ganglioside Modifies α-Synuclein Toxicity and is Neuroprotective in a Rat α-Synuclein Model of Parkinson’s Disease
Retinal α-synuclein deposits in Parkinson’s disease patients and animal models
Characterization of the pathogenic α-Synuclein Variant V15A in Parkinson´s disease
Association of Glial Activation and α-Synuclein Pathology in Parkinson’s Disease
Long-term hyperglycemia aggravates α-synuclein aggregation and dopaminergic neuronal loss in a Parkinson’s disease mouse model
Fasudil attenuates aggregation of α-synuclein in models of Parkinson’s disease
Dermal α-synuclein oligomers and aggregates in Parkinson’s disease
Role of Apolipoproteins and α-Synuclein in Parkinson’s Disease
Phosphorylated α-synuclein in Parkinson’s disease: correlation depends on disease severity
Erythrocytic α-Synuclein as a potential biomarker for Parkinson’s disease
Initiation and progression of α-synuclein pathology in Parkinson’s disease
Structure and dynamics of the aggregation mechanism of the Parkinson's disease-associated protein α-synuclein [alpha-synuclein]
GM1 Ganglioside Modifies α-Synuclein Toxicity and is Neuroprotective in a Rat α-Synuclein Model of Parkinson’s Disease
Retinal α-synuclein deposits in Parkinson’s disease patients and animal models
Characterization of the pathogenic α-Synuclein Variant V15A in Parkinson´s disease
Association of Glial Activation and α-Synuclein Pathology in Parkinson’s Disease